Alzheimer’s drug development pipeline: Positive results, new insight on biomarkers position 2024 as ‘learning year’

April 24, 2024

The world of Alzheimer’s treatments is at an inflection point as more potential drugs make their way out of clinical trials.

Scientists cautiously suggest GLP-1s are safe to use around pregnancy
A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects. Published in the American Journal of Obstetrics and Gynaecology, the study presents the largest ever systematic review of more than 49,000 pregnancies over a period of 20 years that were exposed to GLP-1 receptor agonists.
What do people mean when they say their nervous system is overloaded or needs a reset?
You might have heard people talking about their nervous system being "overloaded" or "dysregulated" when they're going through periods of heightened stress.
Microchip nanoparticle test spots pancreatic cancer in blood, outperforming biopsy in early trial
Scientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer.
New test promises to detect cancer earlier, from tiny particles in bodily fluids
Cancer claims more than 10 million lives every year globally. Research shows that detecting cancer early can greatly improve a patient's chance of survival. And yet we lack reliable, affordable tools for early detection.
People who are blind from birth never develop schizophrenia—what this tells us about the psychiatric condition
In 1950, two researchers noticed something that didn't quite add up. Hector Chevigny, a writer who had lost his sight in adulthood, and psychologist Sydell Braverman were studying the psychological lives of blind people when they stumbled upon an intriguing pattern: schizophrenia, a serious mental illness affecting people across virtually every known society, appeared to be entirely absent in people who had been blind from birth.

Alzheimer’s drug development pipeline: Positive results, new insight on biomarkers position 2024 as ‘learning year’

Recent Posts

JUST IN